Biosistemak participates in the European THCS meeting to bring evidence closer to policy held in Paris
The Institute led two working groups on “Bringing evidence to policy”, focusing on the design of future European masterclasses.
On 2 and 3 June, Paris hosted an international meeting of the European project THCS (European Partnership on Transforming Health and Care Systems), focusing on work package (WP5) “Bringing evidence to policy”. The event, led by the French Ministry of Health, brought together 30 partners and experts in health policy from across Europe to advance the development of tools and strategies that enable policy makers to systematically incorporate scientific evidence into their processes.
Representing Biosistemak, researchers Dolores Verdoy and Maite Zabala led two working groups dedicated to designing future masterclasses, the first of which is scheduled for 2026 under the title ‘Primary and Community Care’. The aim of these training courses is to provide political and technical decision-makers with tools and knowledge to facilitate the integration of scientific evidence into health management and planning.
The sessions held in France addressed the establishment of objectives for the masterclasses, the exchange of experiences between countries and the identification of the needs of policy makers, with the aim of creating useful solutions adapted to the reality of each healthcare system. The working group will continue its work throughout the year and will meet again in the autumn in Romania to follow up on the initiatives agreed in Paris.
About the THCS project
The THCS project is one of the most ambitious European initiatives to transform health and care systems, making them more sustainable, efficient, resilient, inclusive, innovative and of high quality, always people-centred and accessible to the entire population. Its main objective is to contribute to the transition towards more advanced health and care systems, catalysing transformation by building an open and supportive partnership where interested organisations can work together on R&D&I activities.
Coordinated by the Italian Ministry of Health and funded by HADEA (European Health and Digital Executive Agency), THCS has 63 partners and is expected to run for seven years (2023-2029). Within the consortium, the Biosistemak Institute contributes knowledge and tools to define the methodological and evaluation framework of the project and participates in the creation of a European knowledge centre to support the transfer of best practices between member countries.
